Researchers showed that deletion of the epigenetic regulator MLL3, a tumor suppressor frequently altered in human cancer, promoted the acquisition of hybrid epithelial–mesenchymal transition in breast cancer cells.
[Nature Cell Biology]
Home Newsletters Mammary Cell News MLL3 Loss Drives Metastasis by Promoting a Hybrid Epithelial–Mesenchymal Transition State
